Akebia Therapeutics, Inc. (AKBA)
1.425
+0.02
(+1.06%)
USD |
NASDAQ |
Apr 22, 16:00
1.425
0.00 (0.00%)
After-Hours: 16:57
Akebia Therapeutics Total Assets (Quarterly) : 376.56M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 838.03M |
| MannKind Corp. | 792.18M |
| Ligand Pharmaceuticals, Inc. | 1.561B |
| Ardelyx, Inc. | 502.81M |
| Rhythm Pharmaceuticals, Inc. | 481.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 343.96M |
| Shareholders Equity (Quarterly) | 32.61M |
| Debt to Equity Ratio | 6.633 |
| Current Ratio | 1.552 |
| Net Debt Paydown Yield | -1.18% |